stella
beta
A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma — Stella
Recruiting
Back to Mantle Cell Lymphoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality
Shanghai Cancer Center, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov